Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-22-000011
Filing Date
2022-04-04
Accepted
2022-04-04 18:06:44
Documents
1
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3838
  Complete submission text file 0001578563-22-000011.txt   5320
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERECOR INC. 400 EAST PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Miller Joseph M (Reporting) CIK: 0001746372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 22804286